@article{garassino:hal-04143081,
TITLE = {Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study},
AUTHOR = {Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Joo-Hang and Mazi{\`e}res, Julien and Vansteenkiste, Johan and Lena, Herv{\'e} and Jaime, Jesus Corral and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Poole, Lynne and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A},
URL = {https://hal.u-pec.fr/hal-04143081},
JOURNAL = {Lung Cancer},
PUBLISHER = {Elsevier},
VOLUME = {147},
PAGES = {137 - 142},
YEAR = {2020},
MONTH = Sep, DOI = {10.1016/j.lungcan.2020.06.032},
KEYWORDS = {ATLANTIC ; Durvalumab ; NSCLC ; Overall survival ; Safety},
PDF = {https://hal.u-pec.fr/hal-04143081/file/PIIS0169500220305067.pdf},
HAL_ID = {hal-04143081},
HAL_VERSION = {v1},
}